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Abstract
Delay discounting is considered by many to be a risk factor for substance use
disorders and other health-related behavior problems. While these health-related
behavior problems are often treated with incentive-based interventions, little is known
about whether delay discounting (DD) moderates response to that treatment approach.
The present study examined how response to incentive-based smoking-cessation
treatment varied as a function of baseline DD scores among pregnant women
participating in randomized controlled clinical trials examining the efficacy of financial
incentives. Women were assigned to a condition wherein they earned vouchers
exchangeable for retail items contingent on abstinence from recent smoking or to a
control condition wherein they received vouchers of comparable value but independent of
smoking status. Individual differences in DD of hypothetical monetary rewards were
measured at the study intake and follow-up assessments. We examined whether
individual differences in baseline scores on that instrument predict antepartum and
postpartum smoking status using logistic regression, and if sustaining abstinence caused
changes in DD scores from intake to 24-weeks postpartum. We did not see any
significant main effects of DD or interactions of DD with treatment on antepartum or
postpartum smoking status. Treatment condition, baseline smoking rate (cigs/day), a
history of quit attempts pre-pregnancy, and educational attainment were all associated
with increased odds of abstaining from smoking at the late-pregnancy antepartum
assessment, and treatment condition was the only significant predictor of abstaining from
smoking at 24-weeks postpartum, three months after the treatment formally ended. We
saw no discernible evidence that sustained abstinence from smoking was associated with
post-treatment decreases in DD. Overall, we saw no evidence that being a steeper
discounter is associated with a lack of success in quitting smoking in either treatment
condition. Being assigned to the incentives condition was the only predictor of
antepartum and postpartum abstinence. The observed associations of a lower baseline
smoking rate, higher educational attainment, and a history of having attempted to quit
smoking previously with increased odds of success in achieving antepartum smoking
abstinence is consistent with results from previous reports on predictors of response to
this treatment underscoring the reliability of these relationships.
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Introduction
Impulsivity is considered by many to be a risk factor for substance use disorders
and an emerging predictor of treatment outcome among those attempting to discontinue
substance abuse (Baker et al., 2003; Bickel, Odum, & Madden, 1999; Heil et al., 2006;
MacKillop et al., 2007; Madden, Bickel, & Jacobs, 1999; Mitchell, 1999; Vuchinich &
Simpson, 1998; Washio et al., 2011). The construct has been defined as “a predisposition
toward rapid, unplanned reactions to internal or external stimuli [with diminished] regard
to the negative consequences of these reactions to the impulsive individual or others”
(Moeller, Barratt, Dougherty, Schmitz, & Swann, 2001). Rather than being a unified
construct, impulsivity appears to involve multiple dimensions that vary within and
between individuals (Evenden, 1999). The construct is measured in a variety of ways
using diverse assessment tasks or instruments, including the delay-discounting (DD) task,
which is the focus of the present study (Bickel & Marsh, 2001).
Importantly, scores on these various measures of impulsivity are associated with
increased risk for cigarette smoking, other substance use disorders, as well as a wide
range of other health-related behavior problems (e.g., obesity, non-adherence with
medical prevention regimens; de Wit, 2008; Reimers et al., 2009; Swann et al., 2002;
Swann et al., 2004). Increasingly, such health-related behavior problems are being
treated with incentive-based interventions (e.g., see Higgins, Silverman et al., 2012), but
relatively little is known about how type or severity of impulsivity may moderate
response to that treatment approach. To begin addressing that question, I examined how
individual differences in DD predicted response to treatment among pregnant smokers
enrolled in randomized controlled clinical trials examining the efficacy of financial
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incentives in promoting smoking cessation (Higgins, Washio, et al., 2012; Higgins,
Washio, Lopez, et al., 2014). Women in these trials were assigned to an incentive-based
smoking-cessation intervention wherein they earned vouchers exchangeable for retail
items contingent on abstinence from recent smoking or to a control condition in which
vouchers of comparable value were received independent of smoking status.
Background on DD
DD is a behavioral-economic task that is used to examine individual differences
on what can be considered a dimension of impulsivity, namely the rate at which rewards
lose value and aversive events lose salience as delay to their receipt increases (Bickel &
Marsh, 2001). DD was originally characterized in laboratory animals, showing that they
reliably prefer smaller- over larger-magnitude rewards when the former is more
immediately available than the latter (Rachlin & Green, 1972). Moreover, the
relationship between reward value and temporal delay is best described by a hyperbolic
function that is well characterized by the following equation, v= A/(1+kD), whereby
v=discounted value of the delayed reward, A= the undiscounted value of the delayed
reward, k= the measured rate of delay discounting, and D is the delay to the receipt of the
reward (Mazur, 1987). Higher k values indicate greater discounting of future rewards
and can be used to quantify individual differences in discounting.
DD tasks used with humans often involve hypothetical monetary outcomes (e.g.,
Bickel, Odum, & Madden, 1999; Madden et al., 1997). Participants make a series of
choices between immediately available hypothetical monetary rewards and a delayed,
larger amount across different temporal delays. The value of the immediate reward is
systematically adjusted until a value is identified where the participant is indifferent
2

between the immediately available and delayed reward. In other words, the indifference
point is the monetary amount at which the immediately available and delayed options are
valued equivalently. Identifying indifference points across a range of temporal delays
and then fitting Mazur’s hyperbolic equation described above to the data allows one to
quantify the degree to which individual participants discount delayed rewards (Johnson &
Bickel, 2002). Consistent with the results observed in preclinical studies, humans often
prefer the smaller, more immediate over the larger, more delayed reward and the shape of
the discounting function is generally well fit by Mazur’s hyperbolic equation. Although a
comparable titration procedure can be used to quantify discounting of delayed losses, that
procedure has been investigated relatively little overall and, to our knowledge, not at all
with regard to substance abuse treatment response (Odum et al., 2002). Thus the present
study is focused on a version of DD examining sensitivity to delayed hypothetical
rewards (Johnson & Bickel, 2002).
Relationship of Delay Discounting with Health-Related Behavior Problems
As noted above, there is a growing body of empirical evidence demonstrating that
DD is associated with a wide-range of health-related risk behaviors (Bickel et al., 2007;
Davis et al., 2010; Epstein et al., 2010; Rogers et al., 2010). Indeed, excessive
discounting of delayed reinforcers has been proposed to be part of a trans-disease process
that is common to a wide range of health-related risk behaviors (Bickel et al., 2012).
Consistent with that notion, a pronounced bias towards preferring immediate rewards
(i.e., upper 20th percentile of k values on a DD task) predicts a significantly lower
likelihood of adherence to a wide range of preventive services/activities, including
abstaining from cigarette smoking in the longitudinal U.S. Health and Retirement survey
3

(Bradford, 2010). Additionally, greater DD is associated with dependence on cocaine
(Heil et al., 2006), opioids (Madden, Bickel, & Jacobs, 1999), alcohol (MacKillop et al.,
2007; Vuchinich & Simpson, 1998), and nicotine (Baker et al., 2003; Bickel, Odum, &
Madden, 1999; Mitchell, 1999). Greater discounting is also associated with the number
of cigarettes smoked per day (Ohmura, Takahashi, & Kitamura, 2005), and smoking
relapse in laboratory studies (Dallery & Raiff, 2007; Mueller et al., 2009) as well as
outcomes in several clinical trials (MacKillop & Kahler, 2009; Sheffer et al., 2012; Yoon
et al., 2007). There is also at least one trial that is discussed more below in which DD
predicted treatment response in cocaine-dependent outpatients receiving the same
incentive-based intervention that will be investigated in the present study (Washio et al.,
2011) and another noting that greater discounting is associated with poorer treatment
outcomes for cannabis use (Stanger et al., 2012). More recently, a study was conducted
examining whether discounting changes with sustained smoking abstinence (SecadesVilla et al., 2014). In that study, smokers and abstainers showed no differences on DD
immediately post-treatment; however, abstainers were discounting significantly less
compared to smokers at a 12-month follow-up, suggesting that sustained smoking
abstinence is associated with reductions in DD.
Important to note is there have been exceptions to the positive associations
between DD and risk for unhealthy behavioral choices outlined above. For example,
Bradstreet and colleagues (Bradstreet et al., 2012) reported that DD did not differentiate
significantly between pregnant spontaneous quitters and continuing smokers. By
contrast, what might be considered another aspect of impulsivity (e.g., social discounting)
significantly differed between quitters and smokers, with quitters showing less social
4

discounting (i.e., selfishness) than smokers as a function of degree of separation (i.e.,
greater generosity). More recently, White and colleagues (White et al., in press)
conducted a follow-up study to Bradstreet et al. (2012), again examining the ability of
DD to predict spontaneous quitting among pregnant smokers. Social discounting was not
examined in the follow-up study as it was not assessed in the majority of participants
included in this larger study. DD, educational attainment, and smoking rate (cigarettes
smoked per day) were each univariate predictors of quitting. In multivariate analyses,
educational attainment remained a significant predictor and there was a significant
interaction of DD and smoking rate, with DD being a significant predictor at lower but
not higher smoking rates. Turning to studies in the general population of smokers, at
least one study revealed a gender difference with DD discriminating between male but
not female smokers and non-smokers (Jones, Landes, Yi & Bickel, 2009). Lastly, DD
scores at study intake assessment failed to predict treatment outcomes in a study
examining an incentive-based intervention designed to reinforce exercise among college
undergraduates (Pope, 2013).
To our knowledge, the association between DD and response to incentives-based
smoking cessation has not been previously reported. Yoon et al. (2007) reported that
baseline DD predicted relapse back to smoking status at 24-weeks postpartum in a cohort
of women who had quit spontaneously. The studies mentioned above (Bradstreet et al.,
2012; White et al., in press) regarding pregnant smokers examined spontaneous quitting
and not response to a formal intervention. Examining whether DD moderates response to
incentive-based interventions is of particular interest as such interventions are designed to
offer relatively immediate reinforcement for healthy choices and thus might be expected
5

to be more effective than other treatment approaches with steep discounters who may be
unable to tolerate the longer delays typically involved with naturalistic rewards for
quitting smoking during pregnancy (e.g., improved birth outcomes). The results from the
Washio et al. (2011) study on response to incentive-based interventions among cocainedependent outpatients are consistent with that position. Washio and colleagues reported a
significant association between greater DD and lower rates of abstinence in an incentivebased intervention condition with relatively low reinforcement magnitude but not in a
condition with higher magnitude reinforcement. That is, when the magnitude of the
incentives was low and thus less effective, DD predicted abstinence levels. However, as
the magnitude of the incentive value increased and efficacy increased, then the ability of
DD to predict abstinence levels decreased to non-significant levels. Considering that
incentive-based interventions are increasingly being used to effectively alter the same
health-related behaviors for which DD and other types of impulsivity are reported to be
risk factors (Higgins, Silverman, et al., 2012), knowing whether response to incentivebased interventions may vary across different levels of impulsivity severity is an
important question.
Overarching Rationale for the Present Study
The primary purpose of the present study is to examine whether DD predicts
response to abstinence-contingent incentives. While positing that incentive-based
interventions leverage present bias (i.e., an aspect of impulsivity) to promote healthy
choices may be theoretically compelling (Higgins et al., 2012; Loewenstein et al., 2007),
we know of relatively little empirical evidence addressing how impulsivity may moderate
treatment response to incentive-based treatments. Again, the Washio et al. (2011) study
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in cocaine-dependent outpatients mentioned above showed a significant association
between greater DD and lower rates of abstinence in an incentive-based intervention
condition with relatively low reinforcement magnitude and less efficacy but not in a
condition with higher magnitude reinforcement and greater efficacy. Those findings are
consistent with what would be predicted from a present-bias account of the effectiveness
of incentive-based treatments, but we know of no other evidence addressing the role of
impulsivity and response to incentive-based interventions. Important to recognize is that
there are alternative mechanisms through which incentive-based interventions may act to
improve outcomes. For example, financial incentives function as generalized reinforcers
and may simply increase abstinence levels through a reinforcement mechanism
independent of individual differences in sensitivity to delay or other aspects of
impulsivity. As another example, financial incentives increase activity in brain regions
associated with top-down cortical functions underpinning attention, error monitoring, and
other executive functions essential for successful long-term goal seeking (Aston-Jones &
Cohen, 2005; Muller et al., 2007) and that are often diminished among those with
substance use disorders (Garavan & Hester, 2007; Lundqvist, 2005). Perhaps incentives
improve treatment response in part by increasing activation of such self-regulatory
processes. The purpose of the present study is to rigorously characterize the extent to
which response to incentive-based smoking-cessation treatment among pregnant women
varies conditional on individual differences in DD, a widely used task for assessing
individual differences in impulsivity.
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Methods
Participants
Participants (N = 232) were from three randomized controlled clinical trials. Two
of those trials were described in separate reports (Heil et al., 2008; Higgins, Washio,
Lopez, et al., 2014). The third trial was described as part of a review on the use of
incentive-based interventions for smoking cessation among pregnant women (Higgins,
Washio, et al., 2012). Each of the trials were conducted in the same university-based
outpatient research clinic and approved by the local institutional review board.
Participants were recruited from local obstetric clinics and the Federal Special
Supplemental Nutrition Program for Women, Infants and Children in the Burlington,
Vermont area. To be eligible for inclusion, participants had to report currently smoking
at the first prenatal care visit with biochemical verification, reside within the county in
which the clinic is located with no plans to leave the area for 6 months following
delivery, and speak English. Exclusion criteria included incarceration, previous
participation in a trial on incentives for smoking abstinence or living with a trial
participant, current opioid substitution therapy, current use of psychotropic medications
other than antidepressants, being greater than 25 weeks gestation, and living in a group
residence (for more details see Higgins, Washio, Lopez, et al., 2014; Higgins, Washio, et
al., 2012).
Assessments
At the study intake assessment in each of the trials participants completed
questionnaires examining socio-demographics, current smoking status/history, smoking
environment and motivations, confidence and intentions to quit smoking, and provided
8

breath and urine specimens. They also completed the DD task. Abbreviated versions of
the intake assessment were administered again at seven subsequent assessments
completed antepartum (early- and late-pregnancy) and postpartum (2-, 4-, 8-, 12-, and 24weeks). Smoking status was biochemically verified at each assessment using urine
cotinine testing (cutpoint = < 80 ng/ml; Enzyme Multiplied Immunoassay Technique,
Microgenics Corporation, Fremont, CA; a Roche Cobas Mira analyzer, Dade Behring
Inc., Deerfield, IL).
The DD task was completed in a quiet room with a staff member present. The
DD task used a notebook computer running Microsoft Visual Basic 6.0. The DD
program has been described previously (Johnson and Bickel, 2002). Briefly, participants
were seated in front of the computer screen, which displayed the following message:
Imagine that you have a choice between waiting (length of time) and then receiving
$1,000 or receiving a smaller amount of money right away. Please choose between the
two options.

In the instructions, the length of time given was either 1 day, 1 week, 1 month, 6
months, 1 year, 5 years, or 25 years. When participants were ready to begin the task, they
clicked on the start button located on the screen, and the DD program was initiated.
Participants chose between two different options, always a fixed amount ($1,000) at a
fixed delay, or a smaller amount available immediately. The DD program adjusted the
value of the smaller reward across trials according to an algorithm wherein different
values of the smaller reward were presented until an indifference point was found, in
which the value of the smaller, immediate amount was subjectively equivalent to the
delayed $1,000 reward (Johnson & Bickel, 2002). Once the indifference point for a
9

given delay was determined, the next delay was introduced until an indifference point
was established for each of the 7 delays noted above. Delays were presented in a fixed
ascending or descending order for a given participant but determined randomly across
participants. Prior to assessment of each new delay, participants were presented again
with the instructions listed above.
Treatment Interventions
All study participants were assigned to an incentive-based smoking-cessation
intervention wherein they earned vouchers exchangeable for retail items contingent on
abstinence from recent smoking or to a control condition in which vouchers of
comparable value were received independent of smoking status. There was a common
contingent incentives intervention and control condition in each of the trials. One of the
trials also included a third condition, which was a revised contingent incentives condition
that was designed to increase abstinence above levels achieved with the usual incentives
condition. Each of these interventions are described below. Note, however, that the
outcomes achieved with the usual and revised incentive conditions did not differ and thus
were combined for purposes of the present study.
Usual contingent voucher condition (CV). Vouchers redeemable for retail
items were earned contingent on submitting breath CO specimens ≤ 6 ppm during the
initial five days of the cessation effort. Beginning in Week 2, vouchers were delivered
contingent on urine-cotinine levels ≤ 80 ng/ml, a criterion that required a longer duration
of smoking abstinence than breath CO. Voucher delivery was independent of selfreported smoking status and based exclusively on meeting the biochemical-verification
criterion. Vouchers began at $6.25, and escalated by $1.25 per consecutive negative
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specimen to a maximum of $45.00, where they remained barring positive test results or
missed abstinence monitoring visits. Positive test results or missed visits reset the
voucher value back to the original low value, but two consecutive negative tests restored
the value to the pre-reset level. The incentives intervention was in place from study
initiation through 12-weeks postpartum.
Revised contingent voucher condition (RCV). The same voucher schedule as
outlined above was followed in this RCV condition except that potential earnings were
rescheduled, moving $300 forward as bonuses that could be earned during Weeks 1-6 by
meeting a < 4 ppm breath CO criterion during Week 1, testing cotinine negative at the
first urine test on the 2nd Monday of the quit attempt, and thereafter by submitting two
cotinine-negative specimens per week through Week 6. More specifically, bonuses
earned by reaching a cutoff of < 4 ppm CO during Week 1 started at $18.75 and
increased by $3.75 for each successive negative sample reaching a maximum potential
bonus of $33.75 for the 5th consecutive negative specimen meeting the < 4-ppm CO
cutoff during Week 1. Women in this condition earned the same incentive as in the CV
condition if they met the < 6 ppm CO but not the < 4 ppm cutoff in Week 1. Testing
cotinine-negative on the 2nd Monday resulted in an additional bonus of $87.50 above
usual CV incentive earnings on that date. Five more bonuses of $15.50 each were
available on Thursdays (2nd test day of each week) during Weeks 2-6 if a woman also
tested negative for smoking at the earlier test conducted that same week.
Noncontingent voucher control condition (NCV). In this condition, vouchers
were delivered independent of smoking status. Voucher values were $15.00 per visit
antepartum and $20.00 per visit postpartum, values that resulted in payment amounts
11

comparable to average earnings in the CV condition in prior trials (Heil et al., 2008). All
else was the same as in the CV and RCV conditions.
Other services. In addition to the interventions, described above, participants in
all treatment conditions received usual care for smoking cessation provided through their
obstetric clinics, which typically involves provider inquiry regarding smoking status and
a discussion of the advantages of quitting during pregnancy. Study staff provided
additional cessation counseling to all participants during four visits within two weeks of
study entry, at the final antepartum visit, and during three postpartum study visits. For
women who quit during pregnancy, brief counseling also occurred during routine
smoking- status monitoring visits whenever temptations to smoke were reported. As a
counseling guide, we used a printed booklet tailored for pregnant smokers (ACOG,
2001).
Analytical Plan and Statistical Methods
Participant characteristics were compared between treatment conditions using chisquare tests for categorical measures or t tests for continuous variables. As noted above,
results from the revised and usual contingent incentives conditions were collapsed in the
present study. Two measures of smoking abstinence were used in these analyses. First,
we examined antepartum and postpartum point-prevalence abstinence. Smoking
abstinence was defined as a biochemically-verified maternal self-report of no smoking in
the 7-days prior to the assessment.
Regarding the DD task, the hyperbolic model was fitted to each subject’s DD data
using nonlinear regression. Goodness of fit was evaluated on the basis of model R2s and
residual plots. Each subject’s derived discounting parameter (k) was used to compute
12

corresponding ED50 values (1/k) and log transformed k values to account for the skewed
distribution of the discounting score for subsequent analyses. ED50 was used to assist
with interpreting k values, and log k was used in the statistical analyses (Yoon & Higgins,
2008). ED50 values represent the estimated delay at which the immediate value of the
reinforcer was discounted by 50% and provides an intuitive interpretation of the rate of
discounting. For example, a k value of 0.001 equals and ED50 value of 1000 days,
indicating that the delayed outcome lost 50% of its original value in 2.74 years.
The analytic plan was implemented in the following steps: (1) Subject
characteristics were compared between the two treatment conditions. (2) Associations
between intake DD log k values and baseline participant characteristics were conducted
using Pearson’s correlation coefficient. (3) Relationships between DD and smoking
status (late-pregnancy point-prevalence assessment and 24-week postpartum pointprevalence assessment) were assessed using the same correlational analyses as above. (4)
Relationships between baseline characteristics and smoking status were assessed using
the same correlational analyses as above. (5) Logistic regression analysis was used to
examine whether DD scores and treatment condition were independently associated with
smoking status. Furthermore, DD and treatment condition were each entered as
independent explanatory variables in additional models with and without an interaction
term. Next, backward elimination logistic regressions were used to model predictors of
smoking status allowing DD, treatment condition, DD x treatment interaction terms, and
all baseline characteristics that were significantly correlated with impulsivity scores or
smoking status to be considered for inclusion in the model. The criterion for retention in
the regression models was set to alpha = 0.05. Separate regressions were conducted to
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predict 7-day point prevalence abstinence at the late pregnancy and 24-week postpartum
assessments. (6) The final step in the analytic plan examined whether sustained smoking
abstinence was associated with reductions in DD. Women were categorized as smokers
or abstainers based on their 24-week point-prevalence smoking status, and we compared
changes in DD scores from intake to 24-week postpartum within each group using MannWhitney tests and between them at 24-weeks postpartum using Wilcoxon signed-ranks.
All analyses were performed using SAS Version 9 statistical software (SAS Institute,
Cary NC) and SPSS Version 20 (IBM).
Results
Subject Characteristics
On average, participants in this trial were relatively young and economically
disadvantaged (Table 1), with a mean age of less than 25 years, approximately 25% had
less than a high school education, less than 25% had private insurance, and less than 20%
were married. There were no significant differences between the two treatment
conditions on any of the baseline characteristics examined.
Baseline DD Levels and Associations with Baseline Characteristics
Shown in Table 2 are baseline DD scores. Median log k and ED50 values of
study participants were −6.19 and 1.3 years, respectively, meaning that a delay of 1.3
years on average resulted in the value of the delayed hypothetical $1,000 being
discounted by 50% or $500.
DD was significantly correlated with three baseline characteristics (Table 3):
educational attainment (less than a high school education) and two smoking
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characteristics, both having to do with smoking in the home (i.e., living with other
smokers and allowing smoking in the home).
Univariate Predictors of Smoking Status
Treatment condition was significantly correlated with 7-day point prevalence
smoking status at the late-pregnancy and 24-week postpartum assessments (Table 4).
Late-pregnancy smoking status was also significantly correlated with one sociodemographic variable (i.e., less than a high school education) and five baseline smoking
characteristics (i.e., age of first cigarette, cigarettes per day pre-pregnancy, baseline
cigarettes smoked per day, number of quit attempts pre-pregnancy, and number of quit
attempts antepartum but prior to treatment entry). There were no other significant
univariate associations between participant baseline characteristics and late-pregnancy or
24-week postpartum smoking status (Table 4).
Regression Results Predicting Late-Pregnancy Point-Prevalence Smoking Status
As described above, the regressions predicting late pregnancy smoking status
were conducted in four blocks (Table 5). Treatment condition was a significant predictor
while DD was not (Blocks 1 & 2, respectively). There was no significant interaction of
treatment condition and DD (Block 3). The final backwards elimination logistic
regression model (Block 4) included treatment condition, the # of cigarettes smoked per
day at baseline, a history of quit attempts pre-pregnancy, and less than a high school
education. The concordance for this model between the predicted probabilities and latepregnancy smoking status was C =0.78, which indicates strong concordance (i.e., models
are typically considered reasonable when the C-statistic is higher than 0.7 and strong
when C exceeds 0.8 (Hosmer & Lemeshow, 2000; Hosmer & Lemeshow, 1989).
15

Predicting 24-week Postpartum Point-Prevalence Smoking Status
Treatment was a significant predictor of 24-week postpartum point-prevalence
abstinence but DD was not (Block 1 & 2, respectively, Table 6). There was no
significant interaction of treatment and DD (Block 3). Treatment condition was the only
significant predictor retained in the final backwards elimination logistic regression model
(Block 4). The concordance for the model was C = 0.63.
Changes in Impulsivity Over Time
There were no significant changes in DD scores from the intake to 24-week
postpartum assessments when examining all participants independent of smoking status
(Z = 0.62, p = .54). The same was true when women were examined separately based on
their 24-week smoking status. Among women who were non-smokers at 24-weeks
postpartum, median intake log k was -6.36 (ED50 = 1.6) while median 24-week
postpartum log k was −7.18 (ED50 = 3.6; Z = -0.97, p = .33). Among those who were
smokers, median intake log k was -6.33 (ED50 = 1.5) and median 24-weeks postpartum
log k was −5.88 (ED50 = 1.0; Z = .94, p = .35).
Discussion
The primary purpose of the present study was to examine whether response to this
incentive-based treatment for smoking cessation during pregnancy and early postpartum
was moderated by individual differences in DD. There was evidence that greater DD was
associated with the likelihood of living with other smokers and allowing smoking within
the house in the present study. While each of those characteristics have been associated
with smoking during pregnancy in prior studies (Cnattingius, 2004), there was no
16

evidence that DD or those characteristics predicted response to this incentive-based
treatment antepartum or postpartum. There was no evidence of either a main effect of
DD or an interaction with treatment condition. Said differently, there was no evidence
that discounting was associated with outcomes in either the incentives or control
conditions examined.
One possibility as to why we did not see any main effects or interactions with
temporal discounting for delayed hypothetical monetary rewards would be that we do not
have a sufficient range of discounting within this population. Therefore, there would not
be enough of an opportunity to see any moderating response. That does not appear to be
the case. The median baseline log k in the current study was -6.19 with an interquartile
range of 3.23 (ED50 = 1.3). The Washio et al. study (2011) utilizing a cocainedependent sample had an overall median log k of -5.49 with an interquartile range of
3.58 (ED50 = 0.7), and White et al. study (in press) examining spontaneous quitting
among pregnant smokers reported an overall median of -6.52 with an interquartile range
of 3.00 (ED50 = 1.9). Those ranges comparable to the present study and were sufficient
to discern significant associations between DD and changes in smoking and cocaine-use
status.
Turning to what did predict abstinence from smoking in the present study, being
assigned to the incentive-based intervention, smoking fewer cigarettes per day at
baseline, reporting a history of prior quit attempts pre-pregnancy, and attaining a high
school education or more all robustly increased the odds of abstinence at late-pregnancy,
associations that are consistent with those we reported previously for this treatment
approach (Higgins et al., 2009). It is important to note that there is overlap among
17

participants included in the present and prior study, with 114 women (49% of current
sample) having participated in both studies. Nevertheless, the consistency of results
across studies underscores the reliability of these relationships.
We also saw in this current study that being assigned to the incentive-based
treatment was a significant predictor of 24-week postpartum smoking status, which is 3
months after the incentives intervention was discontinued. That association was also
observed in the Higgins et al. (2009) report and in a review of this treatment approach
(Higgins, Washio, et al., 2012), underscoring that the treatment effect is not lost once the
incentives are discontinued, a common criticism of incentive-based interventions.
Indeed, sustaining a treatment effect through the 24-week postpartum period suggests that
the intervention may have fostered a long-term change in smoking status in a subset of
the women treated.
In contrast to a prior report indicating that sustained abstinence reduces
discounting in a general population of smokers (Secades-Villa et al., 2014), we saw no
discernible changes in DD from intake to end of study among abstainers or smokers in
the present study. Women in the present study typically entered treatment at
approximately 10-weeks gestation and most who responded to the intervention would
have quit smoking within the first two weeks of treatment (Higgins et al., 2006) meaning
that many would have been abstinent from smoking for almost 1 year at the time of the
24-week postpartum assessment. That is comparable to the period of sustained
abstinence in the Secades-Villa et al. (2014) study. Yet this length of abstinence was not
associated with a significant reduction in DD values in the present study. Important to
note is that participants in the Secades-Villa et al. study were assessed 1-year post18

treatment compared to only 3-months post-treatment among participants in the present
study. Women in the present study also experienced many unique changes associated
with pregnancy and early postpartum in addition to smoking status, such as hormonal
fluctuations and stress surrounding the pregnancy and postpartum period, which could
have contributed to the different results observed. Further research will be necessary to
more fully characterize the extent to which sustained smoking abstinence is associated
with reductions in DD and individual differences in who may experience that effect.
Because the women included in the present study were all from randomized
controlled trials involving common treatment conditions, we can infer a causal
relationship of treatment and its effects on antepartum and postpartum smoking status.
We cannot similarly infer causality between the associations of baseline smoking rate,
educational attainment, and a history of quitting pre-pregnancy with smoking status in the
present study, but nevertheless can use those associations to further encourage girls to
remain in school at least through high school and hopefully beyond, child-bearing aged
women who do smoke to at least try to quit, and for those who are unable to quit
completely to reduce their smoking rates as low as possible. Those are practices that are
reliably and robustly associated with an increased likelihood of succeeding in quitting
should they become pregnant.
The present study has several limitations that merit mention, including the use of
a relatively small sample size, a cohort selected from a small metropolitan area with an
almost exclusively Caucasian population, and a sample comprised exclusively of women
willing to participate in treatment-outcomes studies. How well this incentivized
treatment model and results from the present study on predictors of a positive treatment
19

outcomes with this approach generalize to more diverse samples and other settings is
largely an unanswered question although controlled trials conducted in at least one other
U.S. state (Oregon) were positive (Donatelle et al., 2004) and an effectiveness study in at
least one other country (Scotland) resulted in positive outcomes (Radley et al., 2013).
Considering the broad generality that has been observed with the use of financial
incentives to decrease use of other substances (Lussier et al., 2006) as well as other
health-related risk behaviors (Higgins, Silverman, et al., 2012) and because these
incentives interventions are based on the fundamental behavioral science principle of
reinforcement (Higgins et al., 2004), we are optimistic that this strategy for reducing
smoking and associated relationships will have generality to diverse samples and settings.
One important future challenge in this research effort is getting a larger proportion of
women to respond and we hope that better understanding who is and is not currently
benefitting from the intervention as was done in the present study will better position us
to accomplish that goal.
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Table 1. Participant characteristics

Overall

Sociodemographics
Age
% <High School Education
% Caucasian
Weeks Preg at Baseline
% Primagravida
% Working for Pay
% With Private Insurance
% Married

Contingent (n = 137)

Noncontingent (n = 99)

p-value

24.4 + 0.3
26.2
93.2
10.1 + 0.3
56.2
49.6
22.0
16.5

24.6 + 0.5
28.2
93.4
9.9 + 0.3
56.6
51.1
25.5
14.6

24.1 + 0.5
23.5
92.9
10.5 + 0.4
55.6
47.5
17.2
19.2

.54
.42
.87
.60
.87
.58
.13
.35

14.7 + 0.2
18.9 + 0.5
9.0 + 0.4
0.7 + 0.1
1.6 + 0.1
67.4
79.2
48.7
21.2

14.9 + 0.3
18.8 + 0.7
8.8 + 0.5
0.8 + 0.2
1.6 + 0.1
69.3
78.8
48.2
22.6

14.4 + 0.3
19.0 + 0.8
9.2 + 0.5
0.7 + 0.2
1.5 + 0.1
64.6
79.8
49.5
19.2

.46
.18
.41
.78
.54
.45
.86
.84
.52

Smoking Characteristics
Age 1st Cigarette
Cigs/day Pre-Preg
Cigs/day at Baseline
Quit Attempts During Preg
NWQ
% History of Quitting Pre-Preg
% Living with Smokers
% No Smoking in Home
% Around None/Few Smokers

Psychiatric Characteristics
Beck Depression Inventory
10.6 + 0.5
10.4 + 0.6
10.8 + 0.7
.38
% History of Depression
36.4
37.2
35.3
.77
Stress Rating
5.5 + 0.2
5.5 + 0.3
5.6 + 0.3
.79
Note: Continuous variables are noted as means ± standard errors and categorical variables are noted as
percentages.
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Table 2. Intake Delay Discounting Scores

Overall

log k median (IQRa)
a
b

Contingent (n = 137) Non-Contingent (n = 99)

-6.19 (3.23) -6.13 (3.10)

Interquartile Range
p-value based on Wilcoxon rank sum test

28

-6.30 (3.33)

p-value

.41b

Table 3. Bivariate Correlations Between Delay Discounting and Other Participant
Characteristics
Log k
r
p-value
.07
.29
.14
.04
.03
.62
.03
.66
-.09
.15
.10
.12
.02
.71
-.03
.63
-.03
.62
-.10
.12
-.08
.20
-.09
.17
-.02
.72
.16
.01
-.13
.04

Age
Less than HS Education
Race
Gestational Age
Working
Private Insurance
Married
Age 1st Cigarette
Cigs/Day Pre-Pregnancy
Cigs/Day Baseline
Quits Pre-Pregnancy
Quits During Pregnancy
NWQ
Living with Smokers
No Smoking Home
Around None/Few Smokers

-.06
.36
-.01
.90
-.01
.90
-.04
.58

BDI
Depression History
Stress
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Table 4. Bivariate Correlations of Treatment Condition, Participant
Characteristics, and Delay Discounting with Smoking Status

Late-Pregnancy

24-wkpp

.27
<.001

.15
.02

Age

.03
.65

.03
.69

Less than HS Education

.14
.03

.04
.53

Race

.08
.23

.08
.21

Gestational Age

-.09
.20

-.003
.97

Working

.10
.12

-.01
.87

Private Insurance

-.03
.66

-.02
.72

Married

-.07
.24

-.02
.77

Age 1st Cigarette

.13
.05

.06
.33

Cigs/Day Pre-Pregnancy

-.19
<.01

-.09
.19

Cigs/Day Baseline

-.24
<.001

-.12
.08

Quits Pre-Pregnancy

.18
<.01

.09
.16

Quits AP

.20
<.01

.05
.48

NWQ

.01
.88

.07
.27

Living with Smokers

.01
.87

.01
.87

No Smoking in Home

.09
.16

.08
.21

None/Few Regular Smokers

-.02
.80

-.02
.79

BDI

.01

.02

Treatment
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.92

.77

Depression History

.003
.97

.01
.85

Stress

.06
.35

.07
.27

Log k

.04
.55

.02
.65

Note: All bivariate correlations were conducted using Pearson’s r.
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Table 5. Logistic Regressions Predicting Late-Pregnancy Point-Prevalence
Abstinence

Block

Chi-Square

O.R. (95% C.I.)

p-value

1. Treatment Alone
Impulsivity Alone

16.65
0.36

4.45 (2.17 – 9.13)
1.03 (0.93 – 1.15)

<.001
.55

2. Treatment Main Effect
Impulsivity Main Effect

17.03
0.26

4.55 (2.21 –9.33)
1.03 (0.92 – 1.15)

<.001
.61

3. Treatment
Impulsivity
Interaction
Log k within Contingent
within Non-contingent

1.77
0.58
0.32

.

18
.45
.57

1.01 (0.88 – 1.15)
1.09 (0.88 – 1.34)

4. Treatment
14.82
Cigs/day at Baseline (per 5 cigarettes) 15.49
Quits Pre-Pregnancy
5.36
Education less than HS
4.27
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4.45 (2.08 – 9.52)
0.47 (0.33 – 0.69)
2.54 (1.15 – 5.61)
0.41 (0.17 – 0.96)

<.001
<.001
.02
.04

Table 6. Logistic Regressions Predicting 24-week Postpartum Point-Prevalence
Abstinence
Block

Chi-Square

O.R. (95% C.I.)

p-value

1. Treatment Alone
Impulsivity Alone

4.55
0.21

3.39 (1.05 – 10.42)
1.04 (0.88 – 1.22)

.03
.65

2. Treatment Main Effect
Impulsivity Main Effect

4.63
0.17

3.43 (1.12 –10.55)
1.03 (0.88 – 1.22)

.03
.68

3. Treatment
Impulsivity
Interaction

0.06
2.64
2.50

4. Treatment

4.55
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.80
.10
.11
3.39 (1.05 – 10.42)

.03

